GENTELL — FDA Facility Profile

FEI 1000522686

GENTELL is an FDA-registered facility (FEI 1000522686) located in Bristol, PA, US. RegDataLab tracks 4 FDA inspections and 1 compliance action at this facility.

Reviewing GENTELL as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check GENTELL yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Sep 16, 2026: No Action Indicated (NAI)
Inspections on record
4 (1 OAI, 1 VAI, 2 NAI)
Last OAI inspection
Aug 25, 2015
Warning letters
1 listed by FDA for this FEI, latest Oct 5, 2015
Recalls as the recalling firm
4, latest Mar 26, 2020

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Sep 16, 2026No Action Indicated (NAI)No citations listed
Dec 12, 2019Voluntary Action Indicated (VAI)Lack of or inadequate procedures - Acceptance activities (21 CFR 820.80(a))
Quality Audit/Reaudit - conducted (21 CFR 820.22)
Management representative (21 CFR 820.20(b)(3))
Management review - defined interval, sufficient frequency (21 CFR 820.20(c))
and 4 more
Dec 13, 2016No Action Indicated (NAI)Supervisor Training/Education/Experience (21 CFR 211.25(b))
Procedures for non-sterile drug products (21 CFR 211.113(a))
Component identity verification (21 CFR 211.84(d)(1))
Testing and release for distribution (21 CFR 211.165(a))
and 7 more
Aug 25, 2015Official Action Indicated (OAI)DHR - not or inadequately maintained (21 CFR 820.184)
Lack of or inadequate complaint procedures (21 CFR 820.198(a))
Lack of or inadequate receiving acceptance procedures (21 CFR 820.80(b))
Lack of or inadequate final acceptance procedures (21 CFR 820.80(d))
and 13 more

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Mar 26, 2020Class IIZ-1907-2020Gentell Honey Hydrogel 2"x2" Saturated Gauze- A hydrating wound dressing containing… and 3 more products
During an FDA audit, it was discovered that the product was not properly registered with FDA.
Feb 27, 2020Class IIZ-1623-2020Gentell Hydrogel Ag 2x2, model no GEN-11220 - Product Usage: Under the care of a… and 3 more products
During an FDA audit, it was discovered that the product was not properly registered with FDA.
Apr 19, 2017Class IID-0866-2017Shield and Protect Moisture Barrier Cream, 1.1% Clotrimazole, Net Weight 4 oz - 115 g…
GMP Deviations; product may not meet cGMP requirements
Dec 15, 2016Class IID-0242-2017Gentell Hydrogel Ag Saturated Gauze, 2"x2"(NDC 61551-112-20), 4x4(NDC 61554-114-24) and… and 1 more product
CGMP Deviations

Facility details

Company
Gentell, Inc
Location
Bristol, PA (US)
Source
device

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.